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Background: Minimal interventional procedures are frequently applied in patients with mechanical low back pain
which is defined as pain presumably resulting from single sources: facet, disc, sacroiliac joint or a combination of
these. Usually, these minimal interventional procedures are an integral part of a multidisciplinary pain programme.
A recent systematic review issued by the Dutch Health Insurance Council showed that the effectiveness of these
procedures for the total group of patients with chronic low back pain is yet unclear and cost-effectiveness
unknown. The aim of the study is to evaluate whether a multidisciplinary pain programme with minimal
interventional procedures is cost-effective compared to the multidisciplinary pain programme alone for patients
with chronic mechanical low back pain who did not respond to conservative primary care and were referred to a
pain clinic.
Methods: All patients with chronic low back pain who are referred to one of the 13 participating pain clinics will
be asked to participate in an observational study. Patients with a suspected diagnosis of facet, disc or sacroiliac joint
problems will receive a diagnostic block to confirm this diagnosis. If confirmed, they will be asked to participate in
a Randomized Controlled Trial (RCT). For each single source a separate RCT will be conducted. Patients with a
combination of facet, disc or sacroiliac joint problems will be invited for participation in a RCT as well. An economic
evaluation from a societal perspective will be performed alongside these four RCTs. Patients will complete
questionnaires at baseline, 3 and 6 weeks, 3, 6, 9 and 12 months after start of the treatment. Costs will be collected
using self-completed cost questionnaires.
Discussion: No trials are yet available which have evaluated the cost-effectiveness of minimal interventional
procedures in patients with chronic mechanical low back pain, which emphasizes the importance of this study.
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Non-specific low back pain is a widespread problem
with major social and economical consequences [1,2].
Non-specific low back pain contains 85 – 90% of the
low back pain diagnoses and is defined as low back pain
not attributable to a recognisable, known specific path-
ology (e.g. infection, tumour, osteoporosis or fracture)
[3-5]. The majority of the patients with low back pain
are successfully treated in primary care, approximately
10 – 15% will develop chronic (more than three months)
symptoms. In The Netherlands, costs of low back pain
were estimated at €3.5 billion in 2007 [6]. Patients devel-
oping chronic symptoms are responsible for the majority
of these healthcare and socio-economic costs [6]. Add-
itionally, based on demographic developments, it is
expected that the number of people with back problems
will increase in the coming years [7,8]. Because of the
enormous costs of this growing problem, effective inter-
ventions aimed at prevention and treatment of chronic
low back pain are necessary.
In lower back pain, 80 – 90% is of mechanical origin
[9,10]. Mechanical back pain implies that the source of
the pain is in the spine or its supporting structures [9].
There is consensus among anaesthesiologists, that min-
imal interventional procedures are effective for patients
with pain presumably resulting from single sources:
facet, disc, sacroiliac (SI) joint or a combination of these
(defined as mechanical low back pain) [11]. This is at
odds with recently performed systematic reviews and
multidisciplinary international clinical guidelines. These
concluded that there is no strong evidence that supports
the effectiveness of minimal interventional procedures in
patients with chronic low back pain [12-17]. Most likely
due to a lack of Randomised Controlled Trials (RCTs)
with a low risk of bias and adequate sample size [12,18].
A recent systematic review issued by the Dutch Health
Insurance Council (CVZ) showed that the effectiveness
of minimal interventional procedures for the total group
of patients with chronic low back pain is unclear and the
cost-effectiveness unknown [19]. Based on this lack of
evidence, CVZ advised the Ministry of Health in The
Netherlands not to reimburse minimal interventional
procedures for patient with chronic low back pain within
the Dutch public health insurance system. The anaesthe-
siologists standpoint is that they merely treat a subgroup
of patients: patients with mechanical low back pain, for
which they argue that minimal interventional procedure
would be effective [11].
Aim
The aim of this project will be to provide a valid, reliable
and precise answer to the question whether minimal
interventional procedures supplementary to a multidis-
ciplinary pain programme for patients with chronicmechanical low back pain who are referred to a pain clinic
are more effective and cost-effective compared with the
multidisciplinary pain programme alone.
Methods
Study design
An observational study and four RCTs with a full eco-
nomic evaluation will be performed. The observational
data will inform about the proportion of patients with a
positive or negative diagnostic test for facet pain, disc
pain, SI-joint pain and a combination of these, and the
clinical outcomes of patients with a negative diagnostic
test. Patients diagnosed with facet, disc, SI-joint or com-
bination pain, by means of a diagnostic block will be
asked to take part of one of the four RCTs. The observa-
tional study will monitor patients who do not want to, or
are not eligible to participate in the RCTs. Figure 1 pro-
vides an overview of the study design and patient flow.
Ethical approval
In June 2012, the study was approved by the Medical
Ethics Committee of the Erasmus Medical Centre in
Rotterdam (registration number MEC-2012-079) and the
study protocol was registered at the Dutch Trial Register
(number NTR3531). Written informed consent will be
obtained before entering the study.
Study population
In this study all patients aged between 18 and 70 years,
referred to a pain clinic with suspected chronic mechan-
ical low back pain and without improvement of symp-
toms after conservative treatment will be invited to
participate in the observational study. Further inclusion
criteria for the RCTs are: a) a 50% or more reduction in
perceived pain at 30 minutes after a diagnostic block; or
b) the provocative discography must be positive. Accord-
ing to the International Association for the Study of Pain
(IASP) and the International Spinal Injection Society
(ISIS), a provocative discography is positive when the fa-
miliar pain at the target level is provoked with a pain
score of 7 out of 10, and two painless adjacent control
discs are present [20].
Exclusion criteria are pregnancy; inability to complete
the questionnaires; anticoagulant drug therapy and/or
coagulopathy; Body Mass Index higher than 35; involve-
ment in a work related conflict; severe psychiatric or
psychological problems. Patients will be asked to complete
five questionnaires, three of which serve to indicate
whether patients with psychiatric or psychological com-
plaints need to be excluded. Distress, depression, anxiety,
somatisation, pain acceptance and pain coping strategies
will be assessed with the Four-Dimensional Symptoms
Questionnaire (4DSQ) [21,22], the Chronic Pain Accept-
ance Questionnaire (CPAQ) [23,24], Hospital Anxiety
Figure 1 Trial design and patient flow.
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(PCI) [27], and the Pain Cognition List (PCL) [28].
Only the 4DSQ (anxiety > 12; depression > 5; distress >
20; somatisation > 20), CPAQ (z-score > 2 in pain will-
ingness) and PCL (z-score > 2 in catastrophizing and
limitations) will be used for exclusion from the RCTs.
Patients will be excluded if they score above the prede-
fined thresh-hold in any of the questionnaires.
Patients are recruited in the pain-treatment clinics of
the participating hospitals. General practitioners and
medical specialists who referred patients to the pain
clinics will be informed about participation of their
patients in the study. The anaesthesiologists identify and
inform potential participants from among their clinic’s
patients. If a patient meets the eligibility criteria and
agree to participate in the trial, the patient will be asked
to sign an informed consent form.
Setting
Anaesthesiologists at the participating clinics will con-
duct the diagnostic tests and the minimal interventional
procedures. Every participating pain clinic has a referral
agreement with three or four physiotherapy practices in
their region. These will provide a standardized exerciseprogramme. The psychological interventions, if necessary,
will take place in a usual care setting.
Multidisciplinary pain programme
Each patient will receive the exercise programme and
psychological help (if necessary). The patient in the inter-
vention group will receive the Minimal Interventional
Procedures as well. Together, this will form the multidiscip-
linary pain programme. The selection of eligible patients in
the diagnostic phase by performing a test block, as well as
the exercise programme (which we standardized for the
study) and the minimal interventional procedures are usual
care at Dutch pain clinics, as described in the current
guideline anaesthesiological pain control [11,29].
Exercise programme
All participants of the trials will receive a standardized
exercise programme based on the guideline low back
pain of the Royal Dutch Society for Physical Therapy
[30]. The programme consists of graded exercise therapy
with focus on quality of movement (local stabilizers) and
behavioural aspects, generally based on the programme of
Lindström et al. [31,32]. As the application of these guide-
lines can vary between physiotherapists, a standardized
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this study in cooperation with Sports Medical Center
Papendal. All physiotherapists participating in the study
have ample experience with exercise therapy with focus
on behavioural aspects. Furthermore, all physiotherapists
will follow a three to four hour introduction session prior
to the study. The main aim of the exercise programme is
restoring physical function. An individually graded exer-
cise programme will be offered to the patient explain-
ing that it is safe to move while increasing the level
of activity. During the exercise programme the patient
has an active role and the physical therapist acts as a
coach and supervisor, using a hands-off approach. The
entire programme will be spread over three months with a
treatment range between eight to twelve hours (one to
two sessions per week).
Psychological support
If necessary, the anaesthesiologist or physiotherapist can
refer the patient to the psychologist. The patients will
receive usual care.
Minimal interventional procedures
Supplementary to the exercise programme, and possibly
a psychological support, the intervention group will re-
ceive minimal interventional procedures. This will take
place according to a pre-specified approach, based on the
current guideline anaesthesiological pain control [11]:
1. Patients with facet joint pain will receive
radiofrequency lesion of the first ramus dorsalis at
Lumbar vertebrae (L)3, L4, L5 and S1.
2. Patients with intervertebral disc pain will receive
Intradiscal Electrothermal Therap (IDET) or
Biacuplasty of the involved disc.
3. Patients with SI- joint pain will receive the Cooled
radiofrequency, radiofrequency lesion pallisade
technique or Simplicity III probe technique of the
ramus dorsalis at L4, L5, S1, S2 and S3.
4. Patients with a combination of the single entities will
be divided, after the clinical diagnosis, to a group
who receives minimal interventional treatments
(i.e. a combination of the interventions mentioned
under 1, 2 and 3).
In both treatment groups, the patients are asked to
refrain from any co-interventions during the interven-
tion period. However, co-interventions after the initial
intervention period will be monitored and evaluated. If
patients in the non-interventional study group have not
improved or recovered after three months, they will not
receive interventional procedures but will return to the
General Practitioner or medical specialist that had re-
ferred them to the pain clinic.Baseline measurement & outcomes
The core set of primary outcomes recommended for low
back pain research will be used [33]. All web-based
questionnaires will be assessed at baseline, three, six,
nine and twelve months after the start of the treatment.
Quality Adjusted Life Years (QALY), pain intensity and
global perceived recovery will be assessed at three and
six weeks as well.
Baseline measurement
The baseline questionnaire includes socio-demographic
characteristics (age, gender, marital status etc.), the com-
plaint history, all primary and secondary outcomes and pa-
tient expectation. Patient expectation will be assessed with
the 10-point scale Credibility/Expectancy Questionnaire
(CEQ) [34,35].
Primary outcomes
There are three primary outcomes: pain intensity, global
perceived recovery and functional status.
Pain intensity over the previous week will be measured
on an 11-point Numerical Rating Scale (NRS) (0 = no
pain to 10 = worst imaginable pain) [36]. Among chronic
low back pain patients, the NRS is the most appropriate,
valid and reliable measurement [37,38].
Global perceived recovery will be measured by self-
assessment on a 7-point NRS ranging from ‘completely
recovered’ to ‘worse than ever’, as for example described
by Kamper et al. [39]. This instrument is often used in
low back pain research [35,40].
Functional status will be measured according to the
Dutch translation of the Oswestry Disability Index (ODI-
NL) [41]. This index consists of ten questions addressing
common daily activities. Each question has six answer
options, scored 0-5, from which 0 is related to ‘no restric-
tion in daily activities’ to 5 ‘the most restrictions in daily
activities’. The ODI has shown to be valid and reliable in
chronic pain experience studies and is widely used in low
back pain research [42,43].
Secondary outcomes
Health-related quality of life will be measured with the
EuroQol (EQ-5D) [44]. This questionnaire assesses five
dimensions (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression) on a 3-point scale
(no problems, moderate problems and severe problems).
This questionnaire is widely used in cost-utility analyses,
and for this purpose applied in the economic evaluation
as well [45,46].
Patient satisfaction will be assessed using a written 7-
point NRS ranging from ‘not satisfied at all’ to ‘completely
satisfied’. No gold standard is available for the measure-
ment of patient satisfaction, but in spinal disorders a
seven-point global question is recommended [33].
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This questionnaire consists of 36 questions, classified in
eight subscales: physical functioning, social functioning,
role limitations (physical problem), role limitations (emo-
tional problem), mental health, pain, general health per-
ception and health change. Scores (ranging from 0-100)
are transformed so that a higher score indicates a better
health status. The Dutch translation of the Rand-36 has
been validated as well [48].
Chronic pain experiences is measured by the Multidi-
mensional Pain Inventory (MPI) [49]. The MPI contains
61 items divided into three parts. The first measures
pain-relevant psychosocial aspects, and contains five
scales. In the second part, the responses of the patient's
partner to the pain (as perceived by the patient himself )
are mapped out. Finally, an inventory is made of the
frequency of common daily activities labelled as house-
hold chores, outdoor work, activities away from home
and social activities, which together form the general
activity level. The MPI (and its Dutch Language Version)
is a valuable instrument for producing reliable and valid
information for therapy-outcome studies with chronic
pain patients [50].
Economic evaluation
The use of care in the pain clinics will be registered by
local research nurses. They will register the type, amount
and results of the diagnostic tests and treatments (interven-
tional procedures) the patients receive. Costs of the multi-
disciplinary pain programme, other health care utilization,
patient and family costs, and production losses will be
included and relevant data collected using self-completed
cost questionnaires [51]. Work absenteeism will be mea-
sured with the Productivity and Disease Questionnaire
(PRODISC), which includes all relevant aspects of the rela-
tionship between health and productivity. The PRODISC
was developed and validated in samples of patients and
employed people in the Netherlands [52]. Costs will be
valued using the guidelines published in the updated hand-
book for economic evaluations in the Netherlands [53]. Ab-
senteeism from paid work will be valued using the friction
cost approach [54].
An overview of the data-collection is presented in
Table 1.
Sample size
Using a power of .9, alpha .05 and a correlation of .5 for
repeated measurements, a total of 85 patients per group
are needed to detect a clinically relevant mean difference
of two points on the NRS for pain intensity (SD 4) [55].
This difference of two points as Minimal Important
Change in the NRS is based on a recent review [55]. An-
ticipating potential study withdrawal (20%) 102 patients
per group or 204 patients per randomized comparisonare needed. In total, 816 patients need to be included in
the four trials.
Through an ‘educated guess’ a SD of four was chosen,
because no SD can be found in the literature. Though
arbitrary, it is believed conservative, and will ensure that
enough patients will be included to find clinically rele-
vant effects, if present.
Treatment allocation
Patients who respond positively to the diagnostic test and
give informed consent will be randomised to either a
group that receives a multidisciplinary pain programme
with the minimal interventional procedures, or a group
receiving a multidisciplinary pain programme alone. The
randomisation will be performed by a local research nurse
in each of the participating pain clinics, using a compu-
terised random number generator. The randomisation list
is developed centrally. Therefore, the research nurse does
not have any influence on the procedure and the treat-
ment allocation is concealed. Randomisation will be strati-
fied for the participating pain clinics. No treatment will be
given prior to randomisation.
Blinding
In this pragmatic trial patients and care providers can-
not be blinded. Because all outcome measures are self-
reported by the patient, the outcome measurement is not
blinded either. Data analysis will be conducted blinded for
treatment allocation and blinding will only be finished
after the final analyses have been concluded. To ensure
data will be analysed anonymously, all patients will be
assigned a unique number. To evaluate whether lack of
blinding is associated with bias, expectations and prefer-
ences of patients will be measured before randomisation
and after treatment allocation. Patient satisfaction will be
measured after treatment and during follow-up.
Statistical analysis
Baseline data will be presented comparing the two treat-
ment groups. Intention-to-treat analysis will be con-
ducted for each follow-up moment. Missing data will be
imputed with multiple imputation techniques [56,57].
The 95%-confidence intervals will be calculated for the
difference of percentages (Chi-square distribution) and
means (T-distribution) for dichotomous and continuous
outcome variables, respectively. In case of unequal distri-
butions of prognostic factors, multivariate analysis techni-
ques will be used to correct for these between-group
differences in prognosis. Multilevel analyses will be per-
formed, with patient, pain clinic, and time of measure-
ment as levels. The threshold of statistical significance is
set at p < 0.05. Characteristics of patients with missing
follow-up data will be compared to those with complete
data to identify possible selective drop-out.
Table 1 Overview of the data collection
Outcome measures Follow-up
Baseline 3 weeks 6 weeks 3 months 6 months 9 months 12 months
Baseline measurements
Demographic data x
Complaint history x
Patient expectation (CEQ) x
Primary outcomes
Pain Intensity (NRS) x x x x x x x
Global perceived recovery (NRS) x x x x x x
Functional Status (ODI) x x x x x
Secondary outcomes
QALY (EQ-5D) x x x x x x x
Patiënt satisfaction (NRS) x x x x
General health (Rand-36) x x x x x
Chronic pain experience (MPI) x x x x x
Economic evaluation
Costs (diaries) x x x x
Work absenteeism (PRODISC) x x x x
Abbreviations: CEQ = Credibility/Expectancy Questionnaire; NRS = Numeric Rating Scale; ODI = Oswestry Disability Index; EQ-5D = EuroQol; MPI = Multidimensional
Pain Inventory; PRODISC = Productivity and Disease Questionnaire.
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The economic evaluation will be performed according to
the intention-to-treat principle and from a societal per-
spective. Costs of the minimal interventional procedures,
physiotherapy, other health care utilization, patient and
family costs, and costs of production losses will be
measured and valued. Data are collected through self-
completed cost questionnaires.
Missing costs and effect data will be imputed using
multiple imputation according to the Multivariate
Imputation by Chained Equations procedure corrected
and accelerated (Bca) bootstrapping with 5000 replications
will be used to estimate confidence intervals around dif-
ferences in total costs between treatment groups [58,59].
A cost-effectiveness and a cost-utility analysis will be
performed. Incremental cost-effectiveness ratios will be
calculated by dividing the difference in mean costs by
the difference in the mean effects of the two treatment
groups. Using a primary clinical effect measures of the
trial, for instance pain intensity. Cost-utility will be
based on the EQ-5D and expressed in costs per QALY.
Uncertainty surrounding incremental cost-effectiveness
and cost-utility ratios will be estimated using boot-
strapping techniques and graphically presented in cost-
effectiveness and cost utility planes. Cost-effectiveness
acceptability curves and net monetary benefit will also be
estimated. Sensitivity analyses on the most important cost
drivers will be performed in order to assess the robustness
of the results.Discussion
The importance of this study is emphasized by the fact
that a recent report did not show consensus regarding
the effectiveness of minimal interventional procedures
for low back pain [60]. This is primarily due to the lack
of RCTs with a low risk of bias and an adequate sample
size. Conversely, minimal interventional procedures are
widely used by anaesthesiologists. Recently published
clinical guidelines of the Dutch Society of Anaesthesiolo-
gists recommend minimal interventional procedures for
a subgroup of patients with low back pain: patients with
mechanical low back pain [11]. The decision whether
reimbursement of minimal interventional procedures in
the Dutch public health insurance system should be con-
tinued needs to be made based upon scientific evidence.
At this moment it is unclear whether reimbursement
should be stopped for the whole group or continued for
the subgroup of patients with mechanical low back pain.
These four RCTs, including an economic evaluation are
designed to provide in this lacking information.
At present, one of the applicants of this study protocol
supervises three randomised, double-blind trials that
evaluate the efficacy of 1) radiofrequency denervation of
the first ramus dorsalis at L3, L4, L5 and S1 in patients
with facet joint pain, of 2) radiofrequency denervation of
the ramus communicans in patients with intervertebral
disc pain, and of 3) radiofrequency denervation of the
ramus dorsalis at L5, S1, S2 in patients with SI joint pain.
These three trials are placebo controlled and do not
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the first on this topic including an economic evaluation.
We did not choose to perform placebo-controlled
experiments. However, because of the nature of the study,
it was not desired to perform a placebo-controlled study
either [61]. Furthermore, both the ethics and feasibility of
performing placebo injections are currently under debate
[62,63]. In our study it will not be possible to determine to
what extent any observed benefits of the minimal inter-
ventional procedures are attributable solely to its placebo
effect, which can be considered a limitation of this trial.
The pragmatic nature of our RCTs mirrors daily practice
which will improve the generalizability [64].
Based on clinical experience we hypothesize that for
patients with chronic mechanical low back pain, a multi-
disciplinary pain programme with minimal interventional
procedures will be more effective than a programme with-
out these procedures. The main expected effect is short-
term pain reduction, but it is likely that this will be asso-
ciated with improved functioning and quality of life.
The costs of minimal interventional procedures are
approximately (depending on the treating hospital and
the health insurance company) between €2500,- and
€3500,- per treatment [65]. We expect that the average
costs of patients who receive minimal interventional
procedures are higher than those of patients in the
control group. However, if clinical outcomes are bet-
ter minimal interventional procedures may be cost-
effective if the incremental costs are worthwhile. Also,
improved clinical outcomes and more rapid recovery
might result in less additional health care consump-
tion and lower costs of work absenteeism and conse-
quently in lower additional costs.
This study will provide more knowledge on the treat-
ment of chronic mechanical low back pain. Furthermore,
results of this project will be included in future updates
of the clinical guidelines of low back pain. The Dutch
Association of Anaesthesiology supports this project and
will use the results in a future update of their clinical
guidelines. Finally, the results of this study will inform
governmental policy regarding reimbursement of mi-
nimal interventional procedures for chronic mechanical
low back pain. The results of the trials are expected to
be available at the end of 2015.Abbreviations
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